Metro Health-University of Michigan Health hired Dr. Susan Sharpe as part of its oncology team.
With the addition of Sharpe, an experienced surgical oncologist, Metro Health is expanding its capability to treat cancer, an illness expected to affect nearly 40% of Americans in their lifetimes.
Cancer is the second cause of death in the United States, close behind heart disease, according to the Centers for Disease Control and Prevention. The National Cancer Institute estimates 38.4% of men and women will be diagnosed with cancer at some point in their lifetime.
Sharpe is board certified in complex general surgical oncology and specializes in the treatment of skin cancer and soft tissue tumors. Her surgical specialties include:
- Esophageal and gastric cancer surgery
- Small bowl surgery
- Gallbladder cancer surgery
- Liver and bile duct surgery
- Pancreatic surgery
“Cancer touches so many lives, including here in West Michigan,” said Dr. Raki Pai, president of the Metro Health Medical Group and chief population health officer. “The addition of Dr. Sharpe helps us fulfill our commitment to stand alongside our patients, whatever they are going through, by growing capabilities and expertise where our patients need it.”
Sharpe also is part of the Cancer Network of West Michigan, a collaborative between Metro Health, Mercy Health and Michigan Medicine to integrate cancer care services in West Michigan. She already is working with Dr. Jill Onesti, a surgical oncologist employed by Mercy Health, to build collaborations and efficient models of care across both institutions.
Sharpe obtained her medical degree from George Washington University School of Medicine and Health Studies. She continued her education with a residency at Rutgers New Jersey Medical School and a fellowship at University of Chicago.
She comes to Metro Health after five years at the Metro Health Medical Center in Cleveland.